# A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering

> **NCT00830154** · PHASE2,PHASE3 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 321 (actual)

## Conditions studied

- Stuttering

## Interventions

- **DRUG:** pagoclone
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT00830154
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-01
- **Final completion:** 2011-01
- **Target enrollment:** 321 (ACTUAL)
- **Last updated:** 2012-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00830154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00830154, "A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00830154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*